false
Catalog
The Liver Meeting 2023
2023 TLM Debrief Session (Hepatitis Debrief)
2023 TLM Debrief Session (Hepatitis Debrief)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Jennifer Price from UCSF provided a comprehensive overview of viral hepatitis, focusing on key themes and highlights from the recent liver meeting. She discussed the ongoing challenges in viral hepatitis elimination, including updated prevalence estimates for hepatitis C in the United States. Dr. Price also highlighted innovative models of care delivery, such as telemedicine-based treatment for people with opioid use disorder. Additionally, she discussed special populations, including hepatitis C in pregnancy and liver transplant recipients. In hepatitis B, Dr. Price covered optimizing therapies, comparing tenofovir and entecavir, and potential novel therapeutics for achieving functional cure. The presentation also touched on screening barriers in Asian American communities and promising research on treatments for hepatitis delta. Dr. Price emphasized the importance of ongoing research and collaboration in addressing the complexities of viral hepatitis.
Asset Caption
Jennifer Price, MD, PhD: Hepatitis Debrief
Keywords
viral hepatitis
liver meeting
hepatitis C
telemedicine
hepatitis B
treatment options
research collaboration
×
Please select your language
1
English